Clinical Trial Update: Radiofrequency Interstitial Tissue Ablation in Treating Patients With Localized Renal Cell Carcinoma (Kidney Cancer) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating radiofrequency interstitial tissue ablation for localized renal cell carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Kidney Cancer | Phase 2 | Status: COMPLETED